HHC
HHC (hexahydrocannabinol) is a hydrogenated cannabinoid with THC-like intoxicating effects, sold in hemp-derived vapes and edibles. Its safety is poorly studied, product quality is inconsistent, and the 2025 federal hemp law effective November 12, 2026 is expected to make most HHC products federally illegal.
Overview
HHC (hexahydrocannabinol) is a hydrogenated form of THC found in only trace amounts in cannabis, so commercial HHC is manufactured, typically from hemp-derived cannabinoids. It produces a THC-like intoxication and became popular as a hemp-derived product after 2018, sold in vapes, gummies, and other formats. It is one of several novel cannabinoids marketed as legal alternatives to marijuana.
Source: peer-reviewed literature (NIH/PMC); Congress.gov (CRS)
Chemistry & mechanism of action
HHC activates the CB1 cannabinoid receptor, the same target as delta-9 THC, which is why it is intoxicating; its effects are broadly THC-like. Commercial HHC is a mixture of two closely related forms that differ in how strongly they bind the receptor. Because it is manufactured by hydrogenating cannabinoids, finished products can contain catalysts, by-products, and residual chemicals from that process.
Source: peer-reviewed literature (NIH/PMC)
Effects
Effects are described as similar to a THC high — relaxation, euphoria, altered perception, increased appetite — with the usual dry mouth, red eyes, and impaired coordination. Users often describe it as somewhere between delta-8 and delta-9 in intensity. As with other poorly dosed hemp cannabinoid products, higher amounts can bring anxiety, paranoia, and rapid heart rate.
Source: peer-reviewed literature (NIH/PMC)
Risks & harms
HHC carries THC-like acute risks — anxiety, paranoia, rapid heart rate, impaired coordination, and over-intoxication at higher doses, especially with edibles — layered on top of a near-total absence of human safety research, so its longer-term and higher-dose risks are essentially unknown. Because it is chemically manufactured from other cannabinoids, products can contain hydrogenation catalysts, residual solvents, by-products, and unlabeled amounts of other cannabinoids, and independent testing repeatedly finds inconsistent and mislabeled potency. Candy-like edibles pose a serious accidental-poisoning risk to children. As with all these products, content and purity cannot be assumed. Keep away from children; if a child ingests a product, or anyone experiences severe distress, chest pain, or cannot be roused, call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.
Source: peer-reviewed literature (NIH/PMC); FDA; Congress.gov (CRS)
Legal status (US)
The legal status of HHC is changing. Under the 2018 Farm Bill's delta-9-only threshold, hemp-derived HHC has been sold in the same gray area as other novel hemp cannabinoids, with varying state restrictions. The 2025 federal law (P.L. 119-37) redefines 'hemp' using total THC and excludes cannabinoids synthesized or manufactured outside the plant; effective November 12, 2026 it is expected to make most HHC products federally illegal. Because this is mid-transition, with possible litigation and further legislation, verify current federal and state law before relying on any status. This page has not yet been medically reviewed.
Source: Congress.gov (CRS); US federal law (2018 Farm Bill; P.L. 119-37, eff. 2026-11-12); DEA
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With cannabis, anxiety or a racing heart usually pass with time. Sit somewhere calm, sip water, and rest — strong edibles in particular can take hours to ease.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 16050328PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-olPubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C21H32O2PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CCCCCC1=CC(=C2[C@@H]3CC(CC[C@H]3C(OC2=C1)(C)C)C)OPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- XKRHRBJLCLXSGE-VNCLPFQGSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- Hexahydrocannabinol, XKRHRBJLCLXSGE-UHFFFAOYSA-NPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- Unknown — pending review
Dosage
Pending medical reviewer
